RIGL

Rigel Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Rigel Pharmaceuticals Inc RIGL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 1.8% 2.26 08:32:01
Open Price Low Price High Price Close Price Prev Close
2.22
more quote information »

Recent News

Date Time Source Heading
1/19/20228:19IHNWFeaturedRevive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
1/19/20228:06IHNWFeaturedGraphano Energy Announces Trading on OTCQB and DTC Eligibility of its Common Shares
1/18/202210:10IHNWFeaturedTocvan Channel Samples 19.8 meters of 0.73 g/t Au and 19.5 meters of 0.61 g/t Au, Releases Trench Program Results
1/18/20229:33IHNWFeaturedVYRE NETWORK PARTNERS WITH DK FILMS INDIA TO EXPAND BOLLYWOOD CONTENT ON ITS "VASOOL TV" CHANNEL
1/13/202207:35TRMNAnalysts Conflicted on These Healthcare Names: Resmed (RMD),..
1/10/202216:15PRNUSRigel to Present at the J.P. Morgan Healthcare Conference
1/10/202212:13SEEKRigel down as it expects slight decrease in products sales..
1/10/202210:45TRMNRigel (RIGL) Gets a Buy Rating from H.C. Wainwright
1/10/202208:40EDGARCurrent Report Filing (8-k)
1/10/202208:40PRNUSRigel Pharmaceuticals Provides Business Update
1/07/202219:00PRNUSRigel Pharmaceuticals, Inc. Announces Inducement Grants..
12/21/202110:15TRMNH.C. Wainwright Thinks Rigel’s Stock is Going to Recover
12/21/202108:55SEEKRigel Pharma says its trial for bleeding disorder therapy..
12/21/202108:30PRNUSFostamatinib Meets Primary Endpoint in Phase 3 Trial in..
12/17/202116:41EDGARCurrent Report Filing (8-k)
12/17/202116:22EDGARStatement of Changes in Beneficial Ownership (4)
12/17/202116:21EDGARInitial Statement of Beneficial Ownership (3)
12/16/202109:00PRNUSRigel Appoints Kamil Ali-Jackson to Board of Directors
11/15/202110:54SEEKRigel Pharma to focus efforts on mid-to-late stage pipeline,..
11/15/202109:01EDGARCurrent Report Filing (8-k)
11/15/202108:30PRNUSRigel Sharpens Focus on Its Advanced Portfolio Opportunities
11/09/202107:30PRNUSRigel to Participate in Two Upcoming Investor Conferences
11/05/202119:02EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202119:00EDGARStatement of Changes in Beneficial Ownership (4)
11/02/202116:05SEEKRigel Pharmaceuticals EPS beats by $0.14, misses on revenue
11/02/202116:04EDGARQuarterly Report (10-q)
11/02/202116:01PRNUSRigel Reports Third Quarter 2021 Financial Results and..
11/01/202117:35SEEKRigel Pharmaceuticals Q3 2021 Earnings Preview
10/26/202107:30PRNUSRigel Announces Conference Call and Webcast to Report Third..
10/08/202116:50PRNUSRigel Pharmaceuticals, Inc. Announces Inducement Grants..
9/10/202108:55EDGARSchedule 13g
9/02/202107:30PRNUSRigel to Participate in Three Upcoming Investor Conferences
9/01/202107:30PRNUSData from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib..
8/13/202116:19EDGARCurrent Report Filing (8-k)
8/13/202108:12DJNRigel: FDA Declines Emergency-Use Authorization for..
8/13/202107:30PRNUSRigel Pharmaceuticals Provides Update on COVID-19 Program
8/03/202117:25EDGARAutomatic Shelf Registration Statement of Securities of..
8/03/202116:27EDGARCurrent Report Filing (8-k)
8/03/202116:07SEEKRigel Pharmaceuticals EPS beats by $0.04, beats on revenue
8/03/202116:05EDGARQuarterly Report (10-q)
8/03/202116:01PRNUSRigel Reports Second Quarter 2021 Financial Results and..
7/27/202107:30PRNUSRigel Announces Conference Call and Webcast to Report Second..
7/14/202107:30PRNUSNew TAVALISSE® Data Analyses To Be Presented at..
6/29/202107:30PRNUSFostamatinib Selected for NIH ACTIV-4 COVID-19 Clinical..
5/26/202107:30PRNUSRigel to Present at the Jefferies Virtual Healthcare..
5/21/202116:01EDGARCurrent Report Filing (8-k)
5/18/202119:02EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202118:56EDGARInitial Statement of Beneficial Ownership (3)
5/14/202109:01EDGARCurrent Report Filing (8-k)
5/14/202107:30PRNUSRigel Appoints Alison L. Hannah, M.D. to Board of Directors
5/05/202116:05SEEKRigel Pharmaceuticals EPS beats by $0.26, beats on revenue
5/05/202116:04EDGARQuarterly Report (10-q)
5/05/202116:02EDGARCurrent Report Filing (8-k)
5/05/202116:01PRNUSRigel Reports First Quarter 2021 Financial Results and..
See more news about this stock »


Your Recent History
NASDAQ
RIGL
Rigel Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.